Human Serum Albumin (HSA) Excipient

CSL Behring is your single source to enhance your innovative products and applications using our safe and high-quality Human Serum Albumin for further manufacturing.

Human Serum Albumin is used as the excipient of choice in many pharmaceutical and biotechnology applications. CSL Behring’s Excipient Albumin can be used as a medium component in cell and gene therapies, cryopreservation, stem cell expansion and cell cultures, as a product stabilizer, as the carrier of molecules in drug delivery, for coatings on medical devices, as a contrast agent, as a protein supplement added to culture media for human IVF and for regenerative medicine. Request Form

CSL Behring’s medical grade HSA batches are manufactured in Bern, Switzerland and are specifically released for excipient use for pharmaceutical, biopharmaceutical and medical device markets. CSL Behring offers the following comprehensive, high-quality service and expertise along with our HSA:

CSL Behring excipient grade HSA batches are manufactured specifically to be used for the pharmaceutical, biopharmaceutical, and medical device markets.

100% human origin, biocompatible and US sourced, contains no genetically modified proteins.

With a multitude of pharmaceutical and biotechnology uses, Human Serum Albumin1 can:

  • Stabilize product potency during manufacturing, shipping, and storage.
  • Provide you with an excipient that occurs naturally in the body and is well tolerated.
  • Act as a carrier molecule/scaffold in drug delivery to transport therapeutic peptides and proteins.
  • Serve as a coating on medical devices.
  • Be used as a component in nanoparticle albumin-bound formulations.
  • Be used as a medium component for:
    • Cell culture
    • Cryopreservation
    • Stem cell expansion

1. Peter T, Jr. All about Albumen. Biochemistry, Genetics and Medical Applications. Academic Press, San Diego, 1996.

CSL Behring also offers Fibrinogen and Thrombin for Manufacturing. For further information please visit our dedicated webpage.